Introduction and Objectives: In France, social inequalities in childhood vaccination have rarely been studied. We conducted a survey to determine whether there were specific...

The data presented in this article pertain to cases of active tuberculosis reported in France during 2012. The number of reported cases of active tuberculosis was 4,975 in 2012 in...

Introduction and Objectives: In light of the expanded marketing authorization for the 13-valent pneumococcal conjugate vaccine (PCV13): 1) To study the incidence and trends of invasive...

Introduction and Objectives: The Bexsero® vaccine received European marketing authorization in early 2013 for the prevention of invasive meningococcal disease (IMD) type B. The High...

Introduction and Objectives: Among invasive meningococcal infections (IMI), serogroup B is the predominant cause in France, and certain clones can lead to prolonged outbreaks. An...

Introduction: Over the past ten years, the annual incidence of invasive meningococcal disease (IMD) in France has ranged from 0.90 to 1.60 cases per 100,000 inhabitants. Neisseria...

Introduction: In 2013, several clusters of mumps cases were reported in communities of young adults, 72% of whom were fully vaccinated (2 doses). The objective of this study was to...

Introduction: Between 2008 and 2012, a measles outbreak occurred in mainland France, with more than 22,000 cases reported through the mandatory reporting system (DO), which has served...

This summary highlights regional disparities in terms of screening activity, positivity rates, and the prevalence of hepatitis B and C: \b7 the French overseas departments (DOM) and...